Home›Stock Screener›Jeevan Scientific Technology›Quarterly Results

Jeevan Scientific Technology Quarterly Results

Latest Quarter Net Profit
₹2 Cr
QMar 2026
Quarterly Results

Jeevan Scientific Technology quarterly results. In Mar 2026, Jeevan Scientific Technology (JSTL) reported revenue ₹22 Cr and net profit ₹2 Cr — revenue +120.0% YoY. For annual financials, live price and key ratios, visit JSTL share price screener.

JSTL Quarterly Results — Revenue, Profit & EPS Highlights

Jeevan Scientific Technology latest quarter revenue, net profit, EPS and QoQ/YoY growth rates. Review JSTL earnings multiple to evaluate earnings-based valuation against sector peers.

  • Revenue of ₹22 Cr in Mar 2026 (+15.8% vs Jun 2026, +120.0% vs Mar 2025)
  • Net Profit of ₹2 Cr in Mar 2026 (+100.0% vs Jun 2026, +300.0% vs Mar 2025)
  • EBITDA of ₹5 Cr in Mar 2026 (+66.7% vs Jun 2026)
  • Operating Margin of 20.0% in Mar 2026 (+4.0pp vs Jun 2026)
  • Earnings Per Share of ₹0.92 in Mar 2026 (+109.1% vs Jun 2026)

Jeevan Scientific Technology Quarterly Results — Revenue, EBITDA, Net Profit & EPS

JSTL quarterly revenue, expenses, EBITDA, net profit, EPS and operating margin with QoQ and YoY comparison.

Metric Mar 2026 Jun 2026 Sept 2025 Mar 2025 Jun 2025 QoQ YoY
Revenue (₹ Cr) 22 19 13 10 9 15.8% 120.0%
Net Profit (₹ Cr) 2 1 0 -1 -3 - -
EBITDA (₹ Cr) 5 3 2 0 -1 - -
EPS (₹) 0.92 0.44 0.01 -0.81 -2.03 - -
Operating Margin (%) 20.0% 16.0% 17.0% -4.0% -20.0% - -

JSTL Share Price Trend — 1-Year Movement Across Quarterly Results

Jeevan Scientific Technology 1-year share price in ₹ overlaid with quarterly earnings dates — NSE/BSE closing prices. Check JSTL company valuation to track the company's total market size over time.

Profitability Ratios

Profit Margin 9.1%
EBITDA Margin 22.7%
Operating Margin 20.0%
ROE (Annual) 11.1%

Balance Sheet Highlights

Total Assets ₹107 Cr
Total Equity ₹72 Cr
Current Assets ₹50 Cr
Current Liabilities ₹14 Cr

Cash Flow Analysis

Operating Cash Flow ₹10 Cr
Investing Cash Flow ₹-16 Cr
Financing Cash Flow ₹5 Cr
Net Cash Flow ₹0 Cr

Current Market Data

Current Price ₹87.33
Exchange BSE
Last Updated Oct 06, 2026

Revenue Trend (₹ Cr)

Mar 2025 10
Sept 2025 13
Jun 2026 19
Mar 2026 22

Net Profit Trend (₹ Cr)

Mar 2025 -1
Sept 2025 0
Jun 2026 1
Mar 2026 2

Operating Margin Trend (%)

Mar 2025 -4.0%
Sept 2025 17.0%
Jun 2026 16.0%
Mar 2026 20.0%

JSTL vs Healthcare Peers — Quarterly Revenue, Profit & Market Cap

Jeevan Scientific Technology latest quarter revenue and net profit vs Healthcare competitors — market cap, price and earnings comparison.

Company Latest Quarter Market Cap (₹ Cr) Price (₹) Revenue (₹ Cr) Net Profit (₹ Cr) Rev QoQ % Rev YoY % Profit Margin % P/E Ratio
Sun Pharmaceutical
Mar 2026 		₹432,120.23 Cr 1804.1 15,018 2,710 -5.6% - 18.0% 159.7
Divis Laboratories
Mar 2026 		₹244,124.91 Cr 9550.0 2,986 751 -5.0% - 25.2% 337.3
Torrent Pharmaceuti…
Mar 2026 		₹188,719.51 Cr 4772.0 4,111 364 +27.7% +42.2% 8.9% 414.6
Zydus Life Science
Mar 2026 		₹113,615.69 Cr 1159.5 7,569 1,341 -4.3% - 17.7% 91.7
Laurus Labs
Mar 2026 		₹109,629.35 Cr 2050.0 1,823 282 -10.5% - 15.5% 396.5
Sector Quarterly Performance Comparison
Healthcare sector • Latest quarterly results
▲ Positive Growth
▼ Negative Growth
- No Data

QoQ: Quarter over Quarter • YoY: Year over Year
All amounts in ₹ Crores